Suppression of BMX-ARHGAP fusion gene inhibits epithelial-mesenchymal transition in gastric cancer cells via RhoA-mediated blockade of JAK/STAT axis.

Journal of Cellular Biochemistry
Xiao-Feng XuYong Ji

Abstract

Gastric cancer (GC) is one of the main causes of cancer-related mortality worldwide. Epithelial-mesenchymal transition (EMT) is an important biological process involving the process by which malignant tumor cells obtain the ability of migration, invasion, resistance of apoptosis, and degradation in the extracellular matrix. The current study aimed at investigating whether bone marrow X kinase Rho GTPase activating protein 12 (BMX-ARHGAP) fusion gene affects GC. First, short hairpin RNA (shRNA) against BMX-ARHGAP or BMX-ARHGAP were introduced to treat SGC-7901 cells with the highest BMX-ARHGAP among the five GC cell lines (SGC-7901, MKN-45, NCI-N87, SNU-5, and AGS). Next, cell vitality, drug resistance, migration, and invasion of SGC-7901 cells, activities of Rho and JAK/STAT axis, as well as EMT and lymph node metastasis (LNM) were evaluated. The survival rate of the mice was then determined through the transfection of the specific pathogen-free NOD-SCID mice with treated SGC-7901 cells. The results showed that BMX-ARHGAP expression was associated with the infiltration degree of GC tumor and poor prognosis for patients with GC. BMX-ARHGAP silencing was found to play an inhibitory role in the Rho and JAK/STAT axis to reduce cell...Continue Reading

References

Jan 1, 1985·Virchows Archiv. A, Pathological Anatomy and Histopathology·G H GriesserH P Horny
Jan 31, 2003·Molecular and Cellular Biology·Stéphane PelletierSylvain Meloche
Jul 31, 2012·World Journal of Gastrointestinal Oncology·Siddavaram Nagini
Oct 9, 2012·Journal of Surgical Oncology·Yelena Y Janjigian, David P Kelsen
Sep 24, 2015·International Journal of Oncology·Puja KhannaGyeong Hun Baeg
Feb 3, 2016·Journal of Translational Medicine·Wenjie DengJun Du
Jan 4, 2017·Anti-cancer Agents in Medicinal Chemistry·Hadeer MohamedOmar Abdel-Rahman
Jan 13, 2017·British Journal of Cancer·Peifei LiJunming Guo
May 26, 2017·Cell Reports·Yiting QiaoMarius Sudol
Aug 16, 2017·Journal of Translational Medicine·Yongjie ShiHongyun Jia

❮ Previous
Next ❯

Citations

Apr 1, 2020·Current Stem Cell Research & Therapy·Haiping LiuXiaodong Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.